XML 44 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Reconciliation of Federal Statutory Rate to Total Effective Rate

 

         
   Year Ended   Year Ended 
   December 31,
2022
   December 31,
2021
 
         
Expected benefit at statutory federal tax rate  $(974,329)  $(979,527)
Permanent differences – net   (859,515)   - 
State and local taxes, net of federal tax benefit   (265,607)   (311,373)
Other   (21,965)   (57,563)
Change in valuation allowance   2,121,416    1,348,463 
Income tax Expense (Benefit) Total  $-   $- 
Schedule of Components of Deferred tax Assets

The components of the Company’s deferred tax assets (liabilities) are as follows:

 

   Year Ended
December 31,
2022
   Year Ended
December 31,
2021
 
Deferred tax assets (liabilities):          
Fixed assets  $(268,594)  $3,837 
Interest   62,310    46,361 
Research and development expenses   454,942    - 
Stock-based compensation   917,351    637,112 
Net operating losses - federal   2,898,411    1,687,053 
Net operating losses – state and local   921,350    536,282 
Net operating losses - foreign   37,686    - 
Research credit   28,985    28,985 
Deferred tax assets gross   5,052,441    2,939,630 
Less valuation allowance   (5,244,441)   (2,939,630)
Net deferred tax liability  $(192,000)  $-